Cargando…

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Xiong, Rui, Zhang, Leike, Li, Shiliang, Sun, Yuan, Ding, Minyi, Wang, Yong, Zhao, Yongliang, Wu, Yan, Shang, Weijuan, Jiang, Xiaming, Shan, Jiwei, Shen, Zihao, Tong, Yi, Xu, Liuxin, Chen, Yu, Liu, Yingle, Zou, Gang, Lavillete, Dimitri, Zhao, Zhenjiang, Wang, Rui, Zhu, Lili, Xiao, Gengfu, Lan, Ke, Li, Honglin, Xu, Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Higher Education Press 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541200/ https://www.ncbi.nlm.nih.gov/pubmed/33029721 http://dx.doi.org/10.1007/s13238-020-00792-w

Ejemplares similares

Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
por: Xiong, Rui, et al.
Publicado: (2020)

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
por: Xiong, Rui, et al.
Publicado: (2020)

A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging Viruses
por: Zheng, Yucheng, et al.
Publicado: (2022)

Rational Design of Benzylidenehydrazinyl-Substituted Thiazole Derivatives as Potent Inhibitors of Human Dihydroorotate Dehydrogenase with in Vivo Anti-arthritic Activity
por: Li, Shiliang, et al.
Publicado: (2015)

DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma
por: Olsen, Thale Kristin, et al.
Publicado: (2022)

DHODH and cancer: promising prospects to be explored
por: Zhou, Yue, et al.
Publicado: (2021)

Immunoglobulin fragment F(ab’)(2) against RBD potently neutralizes SARS-CoV-2 in vitro
por: Pan, Xiaoyan, et al.
Publicado: (2020)

A viral RNA-dependent RNA polymerase inhibitor VV116 broadly inhibits human coronaviruses and has synergistic potency with 3CLpro inhibitor nirmatrelvir
por: Zhang, Yumin, et al.
Publicado: (2023)

Design, Synthesis, and Structure–Activity Relationship Study of Potent MAPK11 Inhibitors
por: Gong, Mengdie, et al.
Publicado: (2021)

DHODH tangoing with GPX4 on the ferroptotic stage
por: Wang, Fudi, et al.
Publicado: (2021)

Oral remdesivir derivative VV116 is a potent inhibitor of respiratory syncytial virus with efficacy in mouse model
por: Zhang, Ruxue, et al.
Publicado: (2022)

Comprehensive interactome analysis of the spike protein of swine acute diarrhea syndrome coronavirus
por: Wang, Qingxing, et al.
Publicado: (2021)

Identification of Potent hDHODH Inhibitors for Lung Cancer via Virtual Screening of a Rationally Designed Small Combinatorial Library
por: Nada, Hossam, et al.
Publicado: (2023)

The Warburg effect modulates DHODH role in ferroptosis: a review
por: Amos, Alvan, et al.
Publicado: (2023)

DHODH: a promising target in the treatment of T-cell acute lymphoblastic leukemia
por: Sexauer, Amy N., et al.
Publicado: (2023)

A Comparative Quantitative Proteomic Analysis of HCMV-Infected Cells Highlights pUL138 as a Multifunctional Protein
por: Li, Yang, et al.
Publicado: (2020)

Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses
por: Lu, Shengsheng, et al.
Publicado: (2021)

IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro
por: Hahn, Friedrich, et al.
Publicado: (2020)

Inactivation/deficiency of DHODH induces cell cycle arrest and programed cell death in melanoma
por: Liu, Lichao, et al.
Publicado: (2017)

The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia
por: Gaidano, Valentina, et al.
Publicado: (2021)

DHODH inhibition modulates glucose metabolism and circulating GDF15, and improves metabolic balance
por: Zhang, Juan, et al.
Publicado: (2021)

Depletion of SOD2 enhances nasopharyngeal carcinoma cell radiosensitivity via ferroptosis induction modulated by DHODH inhibition
por: Amos, Alvan, et al.
Publicado: (2023)

Improvements in SOD mimic AEOL-10150, a potent broad-spectrum antioxidant
por: Zhang, Xiao-rui, et al.
Publicado: (2018)

Visualizing lymphocytic choriomeningitis virus infection in cells and living mice
por: Wen, Yuxi, et al.
Publicado: (2022)

Activation of the STAT3 Signaling Pathway by the RNA-Dependent RNA Polymerase Protein of Arenavirus
por: Wang, Qingxing, et al.
Publicado: (2021)

Naphthoquine: A Potent Broad-Spectrum Anti-Coronavirus Drug In Vitro
por: Song, Yabin, et al.
Publicado: (2022)

A pharmacokinetic drug–drug interaction study between rosuvastatin and emvododstat, a potent anti‐SARS‐CoV‐2 (COVID‐19) DHODH (dihydroorotate dehydrogenase) inhibitor
por: Morton, Terri L., et al.
Publicado: (2023)

Design, synthesis, molecular modeling, and biological evaluation of acrylamide derivatives as potent inhibitors of human dihydroorotate dehydrogenase for the treatment of rheumatoid arthritis()
por: Zeng, Fanxun, et al.
Publicado: (2021)

DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation
por: Mullen, Nicholas J., et al.
Publicado: (2023)

Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
por: Su, Haixia, et al.
Publicado: (2021)

Correction: Depletion of SOD2 enhances nasopharyngeal carcinoma cell radiosensitivity via ferroptosis induction modulated by DHODH inhibition
por: Amos, Alvan, et al.
Publicado: (2023)

Babesia bovis Dihydroorotate Dehydrogenase (BboDHODH) is a Novel Molecular Target of Drug for Bovine Babesiosis
por: KAMYINGKIRD, Ketsarin, et al.
Publicado: (2013)

Exploitation of dihydroorotate dehydrogenase (DHODH) and p53 activation as therapeutic targets: A case study in polypharmacology
por: Ladds, Marcus J. G.W., et al.
Publicado: (2021)

Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors “leflunomide” and “teriflunomide” in Covid-19: A narrative review
por: Kaur, Hardeep, et al.
Publicado: (2021)

The Novel hDHODH Inhibitor MEDS433 Prevents Influenza Virus Replication by Blocking Pyrimidine Biosynthesis
por: Sibille, Giulia, et al.
Publicado: (2022)

Characterisation of putative class 1A DHODH-like proteins from Mucorales and dematiaceous mould species
por: Pinder, Corinne, et al.
Publicado: (2023)

Assessment of a novel variation in DHODH gene causing Miller syndrome: The first report in Chinese population
por: Yang, Kai, et al.
Publicado: (2023)

Comprehensive Interactome Analysis Reveals that STT3B Is Required for N-Glycosylation of Lassa Virus Glycoprotein
por: Zhu, Shenglin, et al.
Publicado: (2019)

A Subcellular Quantitative Proteomic Analysis of Herpes Simplex Virus Type 1-Infected HEK 293T Cells
por: Wan, Weiwei, et al.
Publicado: (2019)

A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses
por: Zhao, Hanjun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pbvhmusdlkika15ukrn3o293rk